These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8318511)

  • 1. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
    Venkatesan S; Cullen P; Pacy P; Halliday D; Scott J
    Arterioscler Thromb; 1993 Jul; 13(7):1110-8. PubMed ID: 8318511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
    Schonfeld G; Aguilar-Salina C; Elias N
    Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
    Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
    Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
    Arad Y; Ramakrishnan R; Ginsberg HN
    Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy.
    Aguilar-Salinas CA; Hugh P; Barrett R; Pulai J; Zhu XL; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):72-82. PubMed ID: 9012640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
    Kissebah AH; Alfarsi S; Evans DJ
    Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; Castro Cabezas M
    J Lipid Res; 2002 Feb; 43(2):274-80. PubMed ID: 11861669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
    Elias N; Patterson BW; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
    J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy.
    Ericsson S; Eriksson M; Berglund L; Angelin B
    J Intern Med; 1992 Oct; 232(4):313-20. PubMed ID: 1402634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride and cholesterol metabolism in primary hypertriglyceridemia.
    Beil U; Grundy SM; Crouse JR; Zech L
    Arteriosclerosis; 1982; 2(1):44-57. PubMed ID: 7059323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL physical and chemical properties in familial combined hyperlipidemia.
    Hokanson JE; Krauss RM; Albers JJ; Austin MA; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):452-9. PubMed ID: 7749856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.